According to a new report by Polaris Market Research, the Europe point of care (PoC) diagnostics market was valued at USD 4.82 billion in 2025 and is projected to reach USD 11.48 billion by 2034, expanding at a CAGR of 10.1% over the forecast period. Growth is underpinned by rising self-testing adoption, expanding digital healthcare infrastructure, and accelerating demand for rapid antimicrobial resistance (AMR) testing across key end-use industries.

What Is Driving Europe Point of Care (PoC) Diagnostics Market Growth?

Demand is climbing as the shift toward decentralized, patient-administered testing converges with supportive government reimbursement policies. Manufacturers and healthcare providers are prioritizing rapid, accessible diagnostics, pushing point of care adoption across clinics, hospitals, and home-care settings. Polaris analysts note that Germany's advanced diagnostic infrastructure and strong reimbursement support position the country for sustained growth through 2034, with infectious disease testing emerging as the largest revenue contributor and the OTC segment posting the fastest incremental gains.

Key Trends Shaping the Europe PoC Diagnostics Industry

AI-Enabled Diagnostic Innovation

AI algorithms are improving the precision of point of care test results by reducing human error and accelerating data interpretation, enabling clinicians to make decisions in minutes rather than hours — a core technology advancement reshaping the industry.

EU Regulatory and Reimbursement Shift

The EU's In Vitro Diagnostic Regulation (IVDR) is raising performance and safety requirements for diagnostic products, tightening the regulatory landscape even as EU4Health funding initiatives support faster development of rapid AMR testing devices.

Rising Demand for Rapid AMR and Chronic Disease Testing

Growing antimicrobial resistance concerns and an aging population managing chronic conditions such as diabetes and cardiovascular disease are reshaping the competitive landscape, pushing vendors toward faster, decentralized testing platforms.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/europe-point-of-care-diagnostics-market 

Market Segmentation: Breaking Down the Europe Point of Care (PoC) Diagnostics Market

Polaris segments the Europe point of care diagnostics market by product, mode of prescription, end use, and country, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Product

The infectious diseases segment led the market in 2025, accounting for 32.4% of revenue, on the strength of rising demand for rapid, accurate outbreak-control testing. Categories aligned with self-testing are expanding quickly as home-based testing gains traction.

By Mode of Prescription

Prescription-based testing dominated the 2025 market share, driven by physician-ordered testing for complex, high-risk conditions. The OTC segment is projected to expand at the fastest CAGR of 11.9% through 2034 as consumers shift toward self-monitoring and home healthcare.

By End Use

Clinics captured the largest share, 37.9%, of end-use revenue in 2025, reflecting demand for fast, affordable outpatient diagnostic services. Hospitals and home-testing settings are gaining ground as decentralized care models spread across the region.

By Country

Germany led the country outlook in 2025 with a 24.8% revenue share, supported by advanced diagnostic infrastructure and strong reimbursement frameworks, while the UK is projected to register the fastest CAGR of 11.6% through 2034 as home-testing solutions and digital healthcare expand.

Regional Outlook: Where Is Europe PoC Diagnostics Growing Fastest?

Germany led the market in 2025 on the back of its well-established healthcare infrastructure and reimbursement support, while the UK is expected to post the fastest CAGR through 2034, driven by rising interest in home-based testing and decentralized care. Within Western Europe, France and Italy round out the top markets, supported by expanding public health screening initiatives and a rising chronic disease burden.

Competitive Landscape: Leading Europe PoC Diagnostics Companies

Key players profiled in the report include bioMérieux, Boditech Med Inc., EKF Diagnostics, Grifols, and HORIBA, Ltd., who are focusing on product launches, capacity expansion, and strategic partnerships to strengthen market position across the infectious diseases and clinics segments outlined above. Recent moves include Abbott's March 2026 completion of its acquisition of Exact Sciences to expand cancer screening capabilities, and the EU Health Technology Assessment Coordination Group's advancement of its 2026 Joint Clinical Assessments program for high-risk diagnostic devices.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the Europe point of care diagnostics market, this report benchmarks market share, segment-level pricing, and forecast data — by product, prescription mode, end use, and country — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking home-testing as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

printed-circuit-board-assembly-market

electric-vehicles-ev-market

top-10-companies-driving-change-in-smart-lighting-market-in-2025-future-of-the-lighting-industry

non-invasive-prenatal-testing-nipt-market

vertical-farming-market

aortic-aneurysm-devices-market

what-are-self-driving-cars-and-how-do-they-work

clean-label-functional-beverage-ingredients-market

carbon-fiber-market